|
|||||
|
|||||
| Application number: | P200200217 | |
| Patent number: | 05036 | |
| PCT application number: | EP00/10210 | |
| Filing date of the application: | 17.10.2000 | |
| Publication date: | 16.06.2003 | |
| Date of the grant of the patent: | 16.06.2008 | |
| Priority date: | 26.10.1999 | |
| Estonian title : | Asendatud indoolid NFkB aktiivsuse moduleerimiseks, nende valmistamismeetod ja kasutamine ning ravim ja selle valmistamismeetod | |
| English title : | Substituted indoles for modulating NFkB activity, a method for preparing thereof, their use, a medicament and a method for preparing the same | |
| Status: | Invalid patent | |
| Fees paid for the years of validity : | 18 | |
| IPC class: | C07D401/04 A61P19/02 A61P29/00 | |
| CPC class: | ||
| Estonian abstract: | Käesolev leiutis käsitleb ühendeid valemiga (I), mis on sobilikud ravimite valmistamiseks selliste haiguslike seisundite profülaktikaks ja raviks, mille korral NFkB aktiisus on tõusnud. Nimetatud ühendid on spetsiifilised IkB-kinaasi inhibiitorid. | |
| English abstract: | The invention relates to compounds of formula (I) which are suitable for the production of medicaments for the prophylaxis and treatment of disease states, the course of wich involves increased NfkB activity. The compounds are specific IkB-kinase inhibitors. | |
| Applicant/holder: |
Sanofi-Aventis Deutschland GmbH | |
| Inventor name: | Olaf Ritzeler (DE) Hans Ulrich Stilz (DE) Bernhard Neises (DE) Gerhard Jaehne (DE) Jörg Habermann (DE) | |
| Drawing(s): Click on the drawing to display a larger drawing! |
|
|
| Published patent application: | Display the published patent application (Document A) | |
| Patent specification: | Display patent specification (Document B) | |
| Patent attorney: | Harald Tehver | |
| Display: | DATA OF THE FEES | |
|
